$0.560
+0.006 (+0.99%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de KTTA por análisis de gráficos similares
Alphio's KTTA stock price prediction model matches the current Pasithea Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.54 (-2.92%). The 1-week path is $0.56 (-0.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Pasithea Therapeutics Corp?
Pasithea Therapeutics Corp (KTTA) appears to be a good buy right now due to its recent positive news and technical indicators. The stock is currently priced at $0.56, with a 5-day change of +3.82% and a 20-day change of +21.77%. The RSI is at 65.184, indicating strong momentum. Additionally, the company received FDA Orphan Drug Designation for its lead candidate, PAS-004, which could enhance its market position and attract investor interest. However, the main risk is the negative earnings trend, with a net income loss of $10,110,868 in Q4 2025, which investors should monitor closely.
KTTA cerró en $0.56 el Friday, tras subir +0.99%
Pasithea Therapeutics Corp (KTTA) last closed at $0.56, gaining +0.99%. These facts feed the 1-day and 1-week KTTA price prediction above.
Factores de la previsión
Los factores de la previsión de Pasithea Therapeutics Corp (KTTA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de KTTA, ordenadas por similitud.
Análisis de estacionalidad de KTTA
Historically the probability of a positive August return for KTTA is 0.00%. April offers the highest probability of a positive month at 7.81%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de KTTA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.72 | $0.72 | $0.75 | +29.38% |
| Sep 2026 | $0.71 | $0.87 | $0.98 | +55.03% |
| Oct 2026 | $0.58 | $0.64 | $0.77 | +14.59% |
| Nov 2026 | $0.61 | $0.74 | $0.75 | +32.08% |
| Dec 2026 | $0.78 | $0.83 | $0.95 | +47.79% |
En 2026, se proyecta que Pasithea Therapeutics Corp (KTTA) oscile entre $0.58 y $0.98.
Previsión mensual de Pasithea Therapeutics Corp para 2026
En Aug de 2026, se proyecta que Pasithea Therapeutics Corp promedie $0.72, con un mínimo de $0.72 y un máximo de $0.75.
En Sep de 2026, se proyecta que Pasithea Therapeutics Corp promedie $0.87, con un mínimo de $0.71 y un máximo de $0.98.
En Oct de 2026, se proyecta que Pasithea Therapeutics Corp promedie $0.64, con un mínimo de $0.58 y un máximo de $0.77.
En Nov de 2026, se proyecta que Pasithea Therapeutics Corp promedie $0.74, con un mínimo de $0.61 y un máximo de $0.75.
En Dec de 2026, se proyecta que Pasithea Therapeutics Corp promedie $0.83, con un mínimo de $0.78 y un máximo de $0.95.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.